HYFT NASDAQ
Credit Risk of going bust: lower than 52% of companies Debt: 4.4% of company value Bonds: none of note held by US funds details ▾
Total debt $2.5M against a stock market value of $54.2M.
Distance to default 5.31 (Merton model): prices to 2026-10-26, balance sheet 2026-07-31, debt counted $345K (short-term plus half of long-term), stock volatility 89.2%; Altman Z'' -32.02. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Austin, TX 78701
US
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Aisling Capital II L | J-Other | 861,826 | — | 2008-03-03 |
| Aisling Capital II L | J-Other | 10,412 | — | 2008-03-03 |
| Aisling Capital II L | J-Other | 1 | — | 2008-03-03 |
| Aisling Capital II L | J-Other | 1 | — | 2008-03-03 |
| Aisling Capital II L | J-Other | 1 | — | 2008-03-03 |